India, Aug. 7 -- The company reported standalone net profit of Rs 1.31 crore for the quarter ended June 30, 2025 as compared to Rs 1.09 crore in the same period last year, registering a year-on-year g... Read More
India, Aug. 7 -- The company reported standalone net profit during the quarter stood at Rs 0.09 crore compared to net loss of Rs 0.02 crore in the previous year quarter. Net revenue of the company ro... Read More
India, Aug. 7 -- Wealth First Portfolio Managers Ltd. on Monday, 12 May 2025, has announced Final dividend of 40 percent on Equity Share, to its shareholders holding shares on the register on Friday, ... Read More
India, Aug. 7 -- The company reported standalone net profit of Rs 60.59 crore for the quarter ended June 30, 2025 as compared to Rs 93.35 crore in the same period last year, registering a year-on-year... Read More
India, Aug. 7 -- The company reported standalone net profit of Rs 0.67 crore for the quarter ended June 30, 2025 as compared to Rs 0.37 crore in the same period last year, registering a year-on-year g... Read More
India, Aug. 7 -- The company reported standalone net profit during the quarter stood at Rs 0.03 crore compared to net loss of Rs 0.26 crore in the previous year quarter. Net revenue of the company ro... Read More
Jakarta, Aug. 7 -- President Prabowo Subianto has called on researchers and industry players to unite in advancing the nation through the 2025 Indonesian Science, Technology, and Industry Convention (... Read More
Guwahati, Aug. 7 -- The newly constructed Terminal 2 (T2) at Guwahati's Lokpriya Gopinath Bordoloi International Airport has been awarded the International Architecture Award 2025 in the Transport cat... Read More
Kargil, Aug. 7 -- The Central Administrative Tribunal (CAT) Srinagar Bench successfully concluded a three days long Circuit Sitting at Tourist Facilitation Centre, Baroo Kargil. The initiative aims t... Read More
India, Aug. 7 -- Genmab A/S (GMAB), Thursday announced positive results from its Phase 3 EPCORE FL-1 trial evaluating subcutaneous epcoritamab in combination with rituximab and lenalidomide for relaps... Read More